Why the study?
Do converting enzyme inhibitors improve arterial compliance and distensibility in hypertensive humans?
Do converting enzyme inhibitors improve arterial compliance and distensibility in hypertensive humans?
Converting enzyme inhibitors improve arterial compliance in hypertensive patients via direct effects on smooth muscle tone, which may help reduce systolic pressure and reverse cardiac hypertrophy.
Answers are grounded in this paper and cite their sources.
May support ACE inhibitor preference in hypertension for vascular benefits beyond BP; leaves open need for prospective RCTs on stiffness outcomes.
Converting enzyme inhibitors enhance arterial compliance in hypertensive humans. The enhancement is due not only to an increase in arterial diameter and volume but also to an increase in arterial distensibility. The latter effect reflects the drug action on arterial smooth muscle tone rather than the lower stretch due to the blood pressure reduction. The improvement in the buffering function of large arteries in hypertensives may contribute to produce a more important decrease in systolic pressure and a better reversion of cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Safar et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: